Psychedelic Drug Treatments : : Assisting the Therapeutic Process / / Ben Sessa, Eileen Worthley.

• VerfasserIn: Sessa, Ben,; Worthley, Eileen,
• Place / Publishing House: Dulles, VA : : Mercury Learning and Information, , [2016]; ©2016
• Year of Publication: 2016
• Language: English
• Series: MyModernHealth FAQs
• Physical Description: 1 online resource (60 p.)
• Other title: Frontmatter --; Contents --; Preface --; Acknowledgments --; PART ONE An Introduction to Psychotropic and Psychedelic Drugs --; An Introduction to Psychotropic and Psychedelic Drugs. Introduction --; CHAPTER 1 Psychoactive Compounds --; CHAPTER 2 Psychedelic Compounds --; CHAPTER 3 A Bit About the Brain --; CHAPTER 4 How Do Psychoactive Medications Work in the Brain? --; PART TWO A Brief History of Research Efforts --; A Brief History of Research Efforts. Introduction --; CHAPTER 5 A Brief History: From Ages Past to Research in the Early 20th Century --; CHAPTER 6 Psychedelic Research and Pioneers in the mid-1900s --; CHAPTER 7 Promising Research Grinds to a Halt --; PART THREE Current Research --; Current Research. Introduction --; CHAPTER 8 Making Pharmaceuticals Legally Available --; CHAPTER 9 Current Research --; CHAPTER 10 Cannabis --; PART FOUR The Future of Psychedelics --; The Future of Psychedelics. Introduction --; CHAPTER 11 The Future for Psychedelic-Assisted Psychotherapy --; CHAPTER 12 Safety Issues, Side Effects, and Ethics --; CHAPTER 13 Opening the Door to a Better Understanding --; Summary --; Appendix --; Index
• Format: Mode of access: Internet via World Wide Web.
• ISBN: 9781937585587
• Access: restricted access
• Hierarchical level: Monograph
• Statement of Responsibility: Ben Sessa, Eileen Worthley.

Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical compounds known as psychedelics affect the brain, provide you with the definitions of key terms particular to the neurological and psychological vocabulary, describe the specific disorders that can realistically be helped or relieved through treatment with psychedelics, and offer information with regard to current research being conducted in the field. This text will discuss the history of the earlier research efforts and will examine the likelihood of a resurgence of interest in the successful development of methods and practices of clinical therapy assisted by psychedelic drugs. The purpose of this volume is to promote an understanding of the use of psychedelics as tools to assist therapy and to challenge the 40-year-old prejudices against research into the possible benefits of these drugs.Features:•Questions and answers about the history, research, and treatments related to psychedelic drugs •Makes a case for the re-evaluation of psychedelics — LSD, MDMA (‘ecstasy’), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more — and their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches.•Includes numerous in-text resources such as links to Web sites, videos, articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical studies